TANAKA PRECIOUS METAL TECHNOLOGIES Develops Miniaturized Micro Profile, a Next-Generation Contact tape for Fifth-Generation Signal Relays

TOKYO, Mar 12, 2025 - (JCN Newswire via SeaPRwire.com) - TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd. (Head Office: Chuo-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), a company engaged in the industrial precious metals business of TANAKA, announces the development of its miniaturized micro profile tape, a next-generation contact for fifth-generation signal…

Eisai Recognized as “2025 Kenko Investment for Health” for the First Time and Certified as “Outstanding Organization Of Kenko Investment for Health Program (White 500)” for the Sixth Time

TOKYO, Mar 10, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has been recognized as the 2025 KENKO Investment for Health by Japan’s Ministry of Economy, Trade, and Industry (METI) and the Tokyo Stock Exchange, for the first time as a company strategically carrying…

Japan’s Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels

TOKYO, Mar 7, 2025 - (JCN Newswire via SeaPRwire.com) - Japan's eight telecommunications companies — Nippon Telegraph and Telephone Corporation, NTT East, NTT West, NTT DOCOMO and NTT Communications (the NTT Group), KDDI Corporation, SoftBank Corp. and Rakuten Mobile — conducted on-site training for the joint use of marine vessels…

Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer’s Disease in Australia

TOKYO and CAMBRIDGE, Mass., Mar 4, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. announced today that the Therapeutic Goods Administration (TGA) of Australia has confirmed the initial decision to decline the approval of humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody lecanemab (generic name) as…

NTT and DOCOMO Successfully Demonstrates On-Demand Unified Control of Computing Services Through Network and Service Integration

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - NTT Corporation (NTT) and NTT DOCOMO, INC. announced today that they have successfully demonstrated the effectiveness and feasibility of In-Network Computing (INC),*1 an architecture that integrates and coordinates computing resources for services such as AI and mobile networks to enable…

Space Compass and NTT DOCOMO Successfully Demonstrate Data Connectivity to 4G Devices via HAPS at 20 km Above Kenya

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Space Compass and NTT DOCOMO, INC. jointly announced today that they have successfully completed data connectivity tests between the LTE base station and smartphones using high-altitude platform stations (HAPS)(1) from the stratosphere (altitudes of around 20km) in Laikipia County, Kenya.In…

Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone

TOKYO, Feb 28, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that the company has entered into a license agreement granting the exclusive development and distribution rights for the fibroblast growth factor (FGF) receptor selective tyrosine kinase inhibitor tasurgratinib succinate (generic name, development code: E7090, Japan…